The 4th International Conference of Pharmaceutical Sciences (ICPS-4)

Under the gracious patronage of Mr. Khalid Eltoukhy, Chairman of the Board of Trustees of Misr University for Science and Technology (MUST); Prof. Dr. Nehad Mahboub, President of the University; Prof. Dr. Rehab Abdelmoneim, Dean of the College of Pharmaceutical Sciences and Drug Manufacturing; and Prof. Dr. Maha Eissa, Vice Dean for Postgraduate Studies and Research Affairs – the College of Pharmaceutical Sciences and Drug Manufacturing at MUST is honored to announce the convening of the 4th International Conference of Pharmaceutical Sciences (ICPS4), under the title:

“Tailored Therapy and Digital Transformation: A New Era of Interdisciplinary Healthcare.”

This prestigious event will be held from September 27 to 28, 2025, and will bring together a distinguished group of leading researchers, prominent figures in the pharmaceutical industry, and innovators in healthcare. The conference will focus on the critical role of interdisciplinary collaboration in advancing personalized medicine, AI-powered drug discovery, and digital health technologies.

The ICPS4 Conference serves as a dynamic platform for knowledge exchange, scientific dialogue, and the establishment of research partnerships. It seeks to integrate the latest scientific advancements with real-world pharmaceutical applications, offering valuable insights into the future of the profession.

In alignment with Egypt Vision 2030, the conference includes a rich agenda of sessions and events that correspond to key national development goals, including:

Goal 1: Quality of life

Goal 2: Justice and inclusion

Goal 3: A strong economy

Goal 4: Knowledge and innovation

Goal 5: Environmental sustainability

Goal 8: Regional and global leadership

Through its focus on ethical practices, innovative digital solutions, and patient-centered approaches, the conference aspires to shape a more efficient and equitable global healthcare system for the future

• Digital therapeutics and smart drug delivery technologies.
• Applications of pharmacogenomics in modern pharmacy.
• The Role of Artificial Intelligence in Shaping the Future of Healthcare.
• Shedding light on pharmacoeconomics in personalized medicine.
• Ethical and regulatory considerations in personalized medicine

1. Shaping the future of precision medicine with interdisciplinary insights.
2. Digital innovation enhances personalized medicine.
3. Pharmacoeconomic outcomes of precision medicine.
4. Ethical, legal and social issues in personalized medicine